These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9263197)
1. Long-term treatment of male F344 rats with deprenyl: assessment of effects on longevity, behavior, and brain function. Bickford PC; Adams CE; Boyson SJ; Curella P; Gerhardt GA; Heron C; Ivy GO; Lin AM; Murphy MP; Poth K; Wallace DR; Young DA; Zahniser NR; Rose GM Neurobiol Aging; 1997; 18(3):309-18. PubMed ID: 9263197 [TBL] [Abstract][Full Text] [Related]
2. Effects of L-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F344 rats. ThyagaRajan S; Madden KS; Stevens SY; Felten DL J Neuroimmunol; 1999 Apr; 96(1):57-65. PubMed ID: 10227424 [TBL] [Abstract][Full Text] [Related]
3. Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of L-deprenyl treatment in young sympathectomized and old Fischer 344 rats. ThyagaRajan S; Felten SY; Felten DL J Neuroimmunol; 1998 Jan; 81(1-2):144-57. PubMed ID: 9521616 [TBL] [Abstract][Full Text] [Related]
4. L-deprenyl-induced increase in IL-2 and NK cell activity accompanies restoration of noradrenergic nerve fibers in the spleens of old F344 rats. ThyagaRajan S; Madden KS; Kalvass JC; Dimitrova SS; Felten SY; Felten DL J Neuroimmunol; 1998 Dec; 92(1-2):9-21. PubMed ID: 9916875 [TBL] [Abstract][Full Text] [Related]
5. Behavioral and neurochemical effects induced by subchronic l-deprenyl administration. Molinengo L; Ghi P Pharmacol Biochem Behav; 1997 Nov; 58(3):649-55. PubMed ID: 9329054 [TBL] [Abstract][Full Text] [Related]
6. Chronic treatment of aged mice with L-deprenyl produces marked striatal MAO-B inhibition but no beneficial effects on survival, motor performance, or nigral lipofuscin accumulation. Ingram DK; Wiener HL; Chachich ME; Long JM; Hengemihle J; Gupta M Neurobiol Aging; 1993; 14(5):431-40. PubMed ID: 8247225 [TBL] [Abstract][Full Text] [Related]
7. Assessing the effects of deprenyl on longevity and antioxidant defenses in different animal models. Kitani K; Kanai S; Ivy GO; Carrillo MC Ann N Y Acad Sci; 1998 Nov; 854():291-306. PubMed ID: 9928438 [TBL] [Abstract][Full Text] [Related]
8. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. Lamensdorf I; Youdim MB; Finberg JP J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937 [TBL] [Abstract][Full Text] [Related]
9. Positive effects of deprenyl and estradiol on spatial memory and oxidant stress in aged female rat brains. Kiray M; Uysal N; Sönmez A; Açikgöz O; Gönenç S Neurosci Lett; 2004 Jan; 354(3):225-8. PubMed ID: 14700737 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine. Paetsch PR; Greenshaw AJ Cell Mol Neurobiol; 1993 Jun; 13(3):203-15. PubMed ID: 8242685 [TBL] [Abstract][Full Text] [Related]
11. The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog. Milgram NW; Ivy GO; Head E; Murphy MP; Wu PH; Ruehl WW; Yu PH; Durden DA; Davis BA; Paterson IA Neurochem Res; 1993 Dec; 18(12):1211-9. PubMed ID: 8272186 [TBL] [Abstract][Full Text] [Related]
12. Region-specific alterations in the concentrations of catecholamines and indoleamines in the brains of young and old F344 rats after L-deprenyl treatment. ThyagaRajan S; Stevens SY; Felten DL Brain Res Bull; 1999 Mar; 48(5):513-20. PubMed ID: 10372512 [TBL] [Abstract][Full Text] [Related]
13. (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. Knoll J Pharmacol Toxicol; 1998 Feb; 82(2):57-66. PubMed ID: 9498233 [TBL] [Abstract][Full Text] [Related]
14. Longevity study with low doses of selegiline/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP). Knoll J; Miklya I Life Sci; 2016 Dec; 167():32-38. PubMed ID: 27777099 [TBL] [Abstract][Full Text] [Related]
15. Maintenance on L-deprenyl prolongs life in aged male rats. Milgram NW; Racine RJ; Nellis P; Mendonca A; Ivy GO Life Sci; 1990; 47(5):415-20. PubMed ID: 2118586 [TBL] [Abstract][Full Text] [Related]
16. L-Deprenyl reverses age-associated decline in splenic norepinephrine, interleukin-2 and interferon-γ production in old female F344 rats. Thyagarajan S; Madden KS; Boehm GW; Stevens SY; Felten DL; Bellinger DL Neuroimmunomodulation; 2013; 20(2):72-8. PubMed ID: 23207416 [TBL] [Abstract][Full Text] [Related]
17. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons. Engberg G; Elebring T; Nissbrandt H J Pharmacol Exp Ther; 1991 Nov; 259(2):841-7. PubMed ID: 1658311 [TBL] [Abstract][Full Text] [Related]
18. Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Zhu J; Hamm RJ; Reeves TM; Povlishock JT; Phillips LL Exp Neurol; 2000 Nov; 166(1):136-52. PubMed ID: 11031090 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of L-deprenyl in rats with carcinogen-induced mammary tumors. ThyagaRajan S; Felten SY; Felten DL Cancer Lett; 1998 Jan; 123(2):177-83. PubMed ID: 9489486 [TBL] [Abstract][Full Text] [Related]
20. Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice. Barber AJ; Yu PH; Boulton AA Life Sci; 1993; 53(9):739-47. PubMed ID: 8355573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]